Short Interest in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Drops By 34.9%

Bioceres Crop Solutions Corp. (NASDAQ:BIOXGet Free Report) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totaling 1,198,641 shares, a drop of 34.9% from the March 15th total of 1,841,462 shares. Approximately 1.9% of the shares of the stock are sold short. Based on an average trading volume of 779,577 shares, the short-interest ratio is currently 1.5 days.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on BIOX shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, March 27th. Canaccord Genuity Group reduced their target price on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a report on Friday, January 2nd. Finally, Wall Street Zen cut shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $4.00.

Read Our Latest Analysis on Bioceres Crop Solutions

Bioceres Crop Solutions Price Performance

NASDAQ:BIOX traded up $0.03 during trading hours on Thursday, reaching $0.61. 110,358 shares of the company’s stock were exchanged, compared to its average volume of 860,024. The company has a market capitalization of $38.32 million, a P/E ratio of -0.16 and a beta of 0.53. Bioceres Crop Solutions has a 12 month low of $0.35 and a 12 month high of $5.18. The company has a quick ratio of 0.69, a current ratio of 0.90 and a debt-to-equity ratio of 0.32. The business’s 50-day simple moving average is $0.52 and its two-hundred day simple moving average is $1.15.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last issued its earnings results on Friday, March 13th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). The business had revenue of $73.67 million for the quarter, compared to the consensus estimate of $104.55 million. Bioceres Crop Solutions had a negative return on equity of 22.43% and a negative net margin of 82.83%. Sell-side analysts expect that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

Institutional Trading of Bioceres Crop Solutions

A number of large investors have recently added to or reduced their stakes in the business. Invesco Ltd. acquired a new position in Bioceres Crop Solutions in the 4th quarter worth approximately $45,000. Ardsley Advisory Partners LP boosted its stake in Bioceres Crop Solutions by 691.7% in the 4th quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock worth $622,000 after purchasing an additional 415,000 shares during the period. GAM Holding AG acquired a new position in Bioceres Crop Solutions in the 4th quarter worth approximately $655,000. State of Wisconsin Investment Board acquired a new position in Bioceres Crop Solutions in the 4th quarter worth approximately $247,000. Finally, Marshall Wace LLP boosted its stake in Bioceres Crop Solutions by 180.0% in the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after purchasing an additional 382,744 shares during the period. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.

Further Reading

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.